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An acute ischemic stroke is characterized by the presence of a blood clot that limits
blood flow to the brain resulting in subsequent neuronal loss. Acute stroke threatens
neuronal survival, which relies heavily upon proper function of astrocytes. Neurons are
more susceptible to cell death when an astrocyte is unable to carry out its normal
functions in supporting the neuron in the area affected by the stroke (Rossi et al., 2007;
Takano et al., 2009). For example, under normal conditions, astrocytes initially swell in
response to changes in extracellular osmotic pressure and then reduce their regulatory
volume in response to volume-activated potassium (K+) and chloride channels (Vella
et al., 2015). This astroglial swelling may be overwhelmed, under ischemic conditions,
due to the increased levels of glutamate and extracellular K+ (Lai et al., 2014; Vella
et al., 2015). The increase in extracellular K+ contributes to neuronal damage and loss
through the initiation of harmful secondary cascades (Nwaobi et al., 2016). Reducing
the amount of extracellular K+ could, in theory, limit or prevent neuronal damage and
loss resulting in an improved prognosis for individuals following ischemic stroke. Kir4.1,
an inwardly rectifying K+ channel, has demonstrated an ability to regulate the rapid
reuptake of this ion to return the cell to basal levels allowing it to fire again in rapid
transmission (Sibille et al., 2015). Despite growing interest in this area, the underlying
mechanism suggesting that neuroprotection could occur through modification of the
Kir4.1 channel’s activity has yet to be described. The purpose of this review is to examine
the current literature and propose potential underlying mechanisms involving Kir4.1,
specially the mammalian target of rapamycin (mTOR) and/or autophagic pathways, in
the pathogenesis of ischemic stroke. The hope is that this review will instigate further
investigation of Kir4.1 as a modulator of stroke pathology.
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GENERAL PROPERTIES OF KIR4.1
Kir4.1, initially named BIR10, was first identified by the Adelman’s group (Bond et al., 1994).
It is predominately expressed on glial cells and is responsible for developmental regulation
of extracellular K+ dynamics (described below) (D’Adamo et al., 2011, 2013). Research has
demonstrated that the channel forms both homomeric Kir4.1-Kir4.1 tetramers and heteromeric
Kir4.1-Kir5.1 tetramers (Hibino et al., 2010; D’Adamo et al., 2011, 2013). The two types of tetramers
have different sensitivities to pH. Between 6.5 and 8.0, the homomeric Kir4.1 channel is inhibited,
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whereas the heteromeric Kir4.1-Kir5.1 is suppressed significantly
(Pessia et al., 2001; D’Adamo et al., 2011, 2013). In addition,
Kir4.1 and Kir5.1 are coexpressed on locus coeruleus neurons
where they appear to be involved in neuronal carbon dioxide
(CO2) chemosensitivity (D’Adamo et al., 2011). Taken together,
these results suggest that pH, CO2, and Kir5.1 subunits modulate
Kir4.1 activity.
Previous research has demonstrated that Kir4.1 channels are
implicated in the pathophysiology of several disease/disorders.
Abnormalities, specifically missense variations, within this
channel have been linked to epilepsy (Hibino et al., 2010;
D’Adamo et al., 2013). For example, a missense variation in
Kir4.1 (T262S) was found to be the reason that DBA/2 mice
are more susceptible to induced seizures than C57BL/6 mice
(Ferraro et al., 2004; D’Adamo et al., 2013). In patients with either
focal or generalized epilepsy, the R271C mutation in the Kir4.1
channel has been associated with a resistance to seizures (Ferraro
et al., 2004; D’Adamo et al., 2013). Another condition, autism
spectrum disorders (ASD), is associated with Kir4.1 channel
mutations. In children with ASD, two specific mutations (R18Q
and V84M) within the Kir4.1 channel have been identified. R18Q
has been associated with several ASD symptoms, such as absence
of speech and severe social interaction deficits, whereas the V84M
appears to confer an increased expression of poor social gaze and
withdrawal behaviors that are also characteristic of ASD (Sicca
et al., 2011; Guglielmi et al., 2015). Kir4.1 abnormalities are also
believed to underlie the comorbidity between epilepsy and ASD
(D’Adamo et al., 2013; Guglielmi et al., 2015). Finally, Kir4.1
activity appears to be altered in response to ischemia (Nwaobi
et al., 2016). Research has shown that Kir4.1 expression and
Kir-mediated currents are reduced from day 1 to day 14 post-
injury following global and focal ischemia (Pivonkova et al., 2010;
Steiner et al., 2012). Furthermore, Kir4.1 channels appear more at
the soma of the astrocyte rather than on the astrocytic processes
when these reductions occur (Stewart et al., 2010; Nwaobi et al.,
2016). It has been suggested that this shift changes Kir4.1 focus to
proliferation instead of K+ spatial buffering (Nwaobi et al., 2016).
THE ROLE OF KIR4.1 IN ASTROCYTIC
FUNCTIONING
Within the central nervous system, astrocytes are involved
in controlling ion and water homeostasis, moving metabolite
and waste products, and participating in the formation of the
blood-brain barrier (Takano et al., 2009; Nwaobi et al., 2016).
These biophysical properties appear to be affected by Kir4.1;
specifically, the homeostasis of extracellular K+, the regulation of
extracellular glutamate, and the mediation of water and volume
levels are three of the processes that Kir4.1 is involved (Nwaobi
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et al., 2016). First, K+ spatial buffering is a process carried out
by astrocytes to ensure that extracellular K+ concentrations are
regulated following an action potential (Nwaobi et al., 2016).
An action potential may increase local K+ concentrations by
1mM under normal neuronal activity or by >10–12mM under
ischemic conditions (Moody et al., 1974; Ransom et al., 2000).
The increased K+ concentrations prevent the neuron from
firing in response to further stimulation and in the case of
ischemic conditions, contribute to neuronal loss (Nwaobi et al.,
2016). Thus, it is important for K+ to be removed from the
extracellular space through a mechanism such as the Kir4.1
channel. This is supported by the fact that at the sites of local
accumulation, Kir4.1 has been shown to allow K+ influx to return
the extracellular K+ concentrations to baseline. Recent work has
demonstrated that local extracellular K+ concentrations were
greater following the blockage of Kir4.1 using barium (Ransom
et al., 2000; Larsen et al., 2014; Nwaobi et al., 2016). Furthermore,
previous work has shown a slower recovery rate of extracellular
K+ concentrations and enhanced undershoot recovery following
brainstem stimulation in glial-conditional Kir4.1 knock out
animals (Neusch et al., 2006). Taken together, these results
implicate the Kir4.1 channel’s involvement in extracellular K+
homeostasis and neuronal survival following ischemia.
Second, astrocytes are involved in glutamate uptake through
two transporters, GLAST (EAAT1) and GLT-1 (EAAT2), in
an energetically unfavorable process (Rothstein et al., 1996).
Sodium, hydrogen and K+ electrochemical gradients work in
concert with the two transporters to bring glutamate into
the astrocyte in an efficient manner (Barbour et al., 1988;
Nwaobi et al., 2016). With respect to extracellular K+, high
concentrations decrease K+ unbinding and depolarize the glial
membrane reducing the amount of glutamate reuptake resulting
in an increase in neuronal excitability (Barbour et al., 1988).
The contribution of Kir4.1 to astrocytic glutamate uptake has
been previously studied. Researchers found a 33.1 and 57.0
percent decrease in glutamate uptake following pharmacological
inhibition and siRNA-mediated Kir4.1 knockdown in cortical
astrocytes (Kucheryavykh et al., 2007). The authors attributed
these decreases to be the result of a loss in the hyperpolarized
resting membrane potential of the astrocyte. In addition,
a TBOA (threo-beta-benzyloxyaspartate)-sensitive glutamate
uptake reduction of >50 percent was seen in Kir4.1 knockout
animals when compared to wild-type animals (Nwaobi et al.,
2016). The results support Kir4.1’s role in glutamate uptake by
allowing the astrocyte to maintain a K+ electrochemical gradient
that promotes K+ unbinding and glial depolarization.
Lastly, a third property of astrocytes that appears to involve
Kir4.1 functioning is water and volume regulation. Aquaporins,
specifically aquaporin 4 (AQP4), are found at the astroglial
endfeet where they are responsible for bringing water into
specific cells and removing excess water to alleviate swelling
to prevent cell lysis (Vella et al., 2015). Under conditions of
water and/or food deprivation, AQP4 has demonstrated an
ability to alter its expression levels in order to maintain the
brain’s normal water content and prevent cell loss (Ye et al.,
2016). Studies examining the relationship between Kir4.1 and
AQP4 have found that they co-localize with one another. For
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example, one study demonstrated that co-immunoprecipitates
between the two were found in Müller cells and that loss or
mislocalization of Kir4.1 in the post-ischemic retina played a role
in glial cell swelling (Pannicke et al., 2004). However, a follow-
up study was able to induce the same cell swelling through the
inhibition, using physostigmine, of Kir4.1 to prevent K+ eﬄux
without changing AQP4 expression or function (Nwaobi et al.,
2016). This suggests that changing Kir4.1 channel’s activity alone,
through the application of different pharmacological agents,
could reduce the amount of cell lysis or autophagic cell death seen
in ischemic conditions.
In addition, due to the interaction between Kir4.1 and
APQ4 channels, an important factor that may modulate Kir4.1
activity is water movement through different compartments.
With a specific focus on glutamate, a review published by
Rothman and Olney (1986) described how neurotoxicity results
in the simultaneous build-up of intracellular sodium, K+, and
water that may lead to lysis/autophagic injury. Glutamate,
a neurotransmitter impacted by K+ gradients and Kir4.1 as
described above, acts on many different receptors to exert its
effects. The two most important ones for the purpose of this
review are α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) and kainite (KA) receptors. These two receptors
are highly permeable to sodium and K+ (Chen et al., 1998).
Over-activation of these receptors, as well as the N-methyl-D-
aspartate (NMDA) receptor, results in response to brain ischemia
(Rothman and Olney, 1987; Coyle and Puttfarcken, 1993). The
over-activation leads to excessive ion influx, osmotic swelling,
free radical generation, and cell death (Rothman and Olney,
1987; Coyle and Puttfarcken, 1993). Specifically, Rothman and
Olney (1986) found that the recovery of water regulation might
also reverse the lysis/autophagic injury. Based on these findings,
water accumulation may also be considered a “stressor” that
damages organelles. Due to the Kir4.1 channel’s interaction with
APQ4, and its involvement in water/volume regulation, further
studies are required to examine how levels of intracellular K+
contribute to such conditions and how the proposed mTOR
pathway involving Kir4.1 (described below; Figure 1) is linked
to cell survival.
POTENTIAL MECHANISMS INVOLVED IN
MEDIATING KIR4.1 FUNCTIONAL
BENEFITS
Kir4.1 channel activity following ischemia and its contribution
to the biophysical properties of astrocytes has previously been
described. How Kir4.1 is involved in preventing neuronal loss
following ischemia through an intrinsic pathway has yet to be
outlined. Specifically, it is possible that Kir4.1 may play a role in
the activation of the mammalian target of rapamycin complex
1 (mTORC1). mTORC1 is one of two mTOR complexes that
contains a kinase mTOR component (Heras-Sandoval et al.,
2014). It is mediated upstream by the phosphatidylinositol 3
kinase/protein kinase B (PI3K/AKT) pathway that is involved
in cell survival and the inhibition of apoptosis (Heras-Sandoval
et al., 2014). Furthermore, researchers have shown that mTORC1
is involved in the negative regulation of autophagy (Noda and
Ohsumi, 1998; Schmelzle and Hall, 2000; Cuyàs et al., 2014).
Autophagy involves the breakdown of damaged organelles
and misfolded proteins via a stress-induced catabolic pathway
that maintains proper cellular homeostasis (Heras-Sandoval
et al., 2014; Sahni et al., 2017). Autophagy does not seem to
always result in cell survival. Autophagic programmed cell death
occurs in response to stressors, such as water accumulation or
nutrient deprivation, due to induced autophagy (Heras-Sandoval
et al., 2014). Induced autophagy has been shown to occur in
response to altered expression of autophage-related gene (Atg) 5
and 6 within the cell leading to cellular lysis (Amelio et al., 2011;
Majid, 2014). Research has also demonstrated that autophagy is
impacted significantly more in nutrient-deprived situations, such
as K+-deprivation, as the process is associated with energy re-
usage in cells (Ye et al., 2016; Sahni et al., 2017). For example,
within cerebellar granule cells, K+-deprivation has not only
induced autophagy but has been linked to programmed cell death
as conditions move into K+-starvation (K+ reduced to 5mM)
(Canu et al., 2005; Kaasik et al., 2005; Sahni et al., 2017). Kir4.1
is dependent on adenosine triphosphate (ATP) (Nwaobi et al.,
2016). Under K+-starvation, Kir4.1 may be inactive as a result
of ATP depletion in response to brain ischemia and low pH
due to the acidosis that occurs in response to ischemia (Pessia
et al., 2001; Hu and Song, 2017). As a result, Kir4.1 is no longer
activated in a PI3K-dependent manner (as suggested below) and
mTORC1 no longer prevents autophagic cell death.
The point at which PI3K attempts to activate Kir4.1 appears
to be dependent on timing. This may be because recent evidence
has pointed not only to the dual role of autophagy following
ischemia (Chen et al., 2014; Majid, 2014) but implicates the
potential role of K+ in preventing autophagy (Canu et al.,
2005; Kaasik et al., 2005; Sahni et al., 2017). Initially, Koike
et al. (2008) demonstrated that the induction of autophagy,
following hypoxia-ischemia injury, results in neuronal death. On
the other hand, Carloni et al. (2010) described a pro-survival
signaling complex involving autophagy to prevent neuronal
death. More recently, it was suggested that the role autophagy
plays following ischemia is determined by the time at which it is
induced (Chen et al., 2014). Ravikumar et al. (2010) stated that
a protective role for autophagy might be seen during ischemic
preconditioning, whereas following ischemia/reperfusion the
process might aggravate cerebral ischemic injury. Based on
these findings, He et al. (2012) hypothesized that inducing
autophagy at different time points during early and late stage
ischemia may account for the different outcomes. For example,
infarct size was reduced significantly and eliminated water
content increases in the brain after treatment with 3-MA
(a known autophagy inhibitor) prior to reperfusion (Chen
et al., 2014). On the other hand, Carloni et al. (2010) found
that treatment with rapamycin decreased brain injury and
increased autophagy when administered prior to hypoxia-
ischemia. Furthermore, the neuroprotective effects of ischemic
postconditioning, previously described as being mimicked (Yan
et al., 2011), are weakened when rapamycin is applied at the onset
of reperfusion rather than at the onset of hypoxia-ischemia (Gao
et al., 2012).
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FIGURE 1 | The proposed intrinsic mechanism involving Kir4.1 in neuronal survival following ischemia. (A) Following ischemia, the levels of extracellular potassium
increase significantly. PI3K is recruited to activate Kir4.1 leading to the initiation of mTORC1 and the overall mTOR pathway. In addition, it is possible that p62 is
recruited to regulate Kir4.1. As a result, more cells in the ischemic penumbra survive and brain injury is reduced. Treatment with rapamycin has been demonstrated to
reduce these effects. (B) During potassium starvation Kir4.1 is not activated due to ATP-depletion and mTORC1 no longer negatively regulates autophagy. Instead,
autophagic cell death via protein breakdown in the autolysosome is initiated in a PI3K-dependent manner. Under these conditions, p62 interacts with ubiquitin (Ub)
and binds with Atg8/LC3 within the phagophore. Lysosomes then interact with the autophagosome to form the autolysosome. 3-MA is an inhibitor of the PI3K
pathway that prevents the initiation of autophagic cell death. Ubiquitin is the only molecule that is depicted as potentially feeding back in the mechanism, however,
many other molecules are known to feedback in both the mTOR and autophagic pathways, respectively.
The mammalian target of rapamycin (mTOR) pathways is one
of several cellular pathways that are involved in the maintenance
of neuronal survival. It is also inhibited by rapamycin. As
mentioned above, the timing at which PI3K attempts to activate
Kir4.1, resulting in mTORC1 activation, may determine which
pathway is activated leading to either cell survival or death. It is
possible that targeting Kir4.1 activity prior to reperfusion may
increase PI3K activity, and subsequent AKT phosphorylation,
resulting in the activation of the mTORC1. It is important to
note that the channel’s involvement in the mTOR pathway has
only been previously implicated by a single study. Zaika et al.
(2016) showed that using insulin and insulin-like growth factor-
1, within the cortical collecting duct, activates the heteromeric
Kir4.1/Kir5.1 channel in a phosphoinositide 3-kinase (PI3K)-
dependent manner. It is possible that Kir4.1 works through
the mTOR pathway to prevent the induction of autophagy,
through its PI3K-dependent activation (Zaika et al., 2016),
following the onset reperfusion leading to the reduction of
infarct size and a decrease in water content. This hypothesis
is supported by the fact that during the onset of reperfusion
ATP levels are high (Murphy and Steenbergen, 2008; Kalogeris
et al., 2012), which corresponds to the time when Kir4.1 is
optimally activated (Takumi et al., 1995; Kucheryavykh et al.,
2009) and APQ4 levels remain unaltered (Shin et al., 2011). On
the other hand, when energy levels are low, corresponding to
Kir4.1 inactivation, the PI3K/AKT pathway is less active leading
to the adoption of a quiescent state by the cells (Cheung and
Rando, 2013). Thus, it is hypothesized that Kir4.1 is activated
in PI3K-dependent manner, leading to cell survival through the
mTOR pathway. Future research could focus on determining the
upstream effectors within this intrinsic pathway and suggests that
Kir4.1 represents a potential therapeutic target for the treatment
of ischemic insult. The two potential mechanisms involved
in mediating Kir4.1 functional benefits are summarized in
Figure 1.
It is also important to note that p62, an adapter molecule
in autophagy, may also play a role in this pathway. Voltage-
gated K+ channels (Kv) are regulated by p62 (Sahni et al.,
2017). It has been previously demonstrated that PKCζ interacts
with p62 to increase the phosphorylation of the β subunit of
Kv (Kvβ) (Puls et al., 1997; Ishii et al., 2013). As a result, Kv
channels, specifically Kv1.5, are inhibited under acute hypoxia
(Ishii et al., 2013). While Kir4.1 is not a voltage-gated channel,
as it lacks a voltage-sensing domain, PKC isoforms have been
shown to modulate both inwardly rectifying and voltage-gated
channels (Dini et al., 2006). For example, the heteromeric Kir4.1-
Kir5.1 channel is inhibited in a PKC-dependent manner (Rojas
et al., 2007). Assuming p62 and Kir4.1 do interact, the timing
at which p62 attempts to interact with Kir4.1 may determine
which pathway is activated leading to either cell survival or death.
Immediately following ischemic onset, p62 may be recruited to
regulate Kir4.1, which is activated in a PI3K-dependent manner,
leading to cell survival through the mTOR pathway (Figure 1A).
Thus, it is possible that targeting Kir4.1 prior to reperfusion, with
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different pharmacological agents, may increase the likelihood of
p62 associating with Kir4.1 and subsequent cell survival. On
the other hand, the point at which p62 attempts to interact
with Kir4.1 would be dependent on timing. This is because as
more ATP is used, Kir4.1 is no longer active and p62 would be
able to associate with ubiquitin to initiate autophagic cell death
under nutrient-deprived situations (Figure 1B). Future research
should examine whether or not the homomeric Kir4.1 channel is
inhibited by PKC isoforms, specifically PKCζ, and if there is an
interaction between Kir4.1 and p62.
CONCLUSION
Previous evidence points to an intrinsic pathway, involving
the regulation of Kir4.1, within the central nervous system
that regulates neuronal survival. Further understanding of this
pathway within astrocytes, and how it impacts neuronal viability
(example: the impact on autophagy), could improve treatment
options following ischemia. In this regard, further research
is critical to identifying the potential role of Kir4.1 channel,
and its subsequent effectors, in ischemia in order to guide
the development of novel treatment options for stroke. These
treatment strategies could be focused on altering Kir4.1 channel
activity, which may be useful in improving the clinical outcomes
after ischemic stroke.
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